The UK has become the first country in Europe to approve a new once-a-day pill to aid weight loss and treat type 2 diabetes.
Orforglipron, known as Foundayo and made by pharmaceutical giant Eli Lilly, was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday.